Table 1 Demographics of Patients and Control subjects
From: Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort
ALL | LRRK2 G2019S carriers | ||||
|---|---|---|---|---|---|
Patients | Controls | p-value | Patients | Controls | |
N | 250 | 218 | 84 (33.6%) | 3 (1.3%) | |
Sex ratio (Men:Women) | 1.2 (136:114) | 1.1 (112:106) | 0.51 | 1.1 (44:40) | 2 (2:1) |
Mean age (years, SD) | 65.8 (10.8) | 62.2 (10.5) | 0.34 | 64.1 (11.5) | 55.3 (7.5) |
Median age (years, IQR) | 66 (59–75) | 61.5 (53–71) | 64 (57–74) | 55 (48–63) | |
Mean age at onset (years, SD) | 58.5 (12.3) | – | 56.1 (12.7) | – | |
Median age at onset (years, IQR) | 59 (49–67) | – | 57 (46–65) | – | |